Literature DB >> 2057752

[Ultrasound screening of the neonatal hip: results and experiences].

R Ganger1, F Grill, S Leodolter, M Vitek.   

Abstract

1291 newborn were examined sonographically between May 1986 and June 1987. Some of them were followed up radiologically until February 1989. The schedule of examination and treatment is given below. Neonatal examination suggested the immediate treatment of 3.25% of the newborn (1.97% of all hips), either Pavlik harness or abduction brace. The mean duration of therapy was 4.3 months. At the end of therapy type I was always in evidence. Patients with severe dysplasia (Graf type IIc or worse) were followed up radiologically at the end of the 2nd year of life. An avascular necrosis of the femoral head was not observed; in one case there was an acetabular index of 30 degrees; the remaining hip joints showed normal findings. We conclude that ultrasound examination in the neonatal period is a worthwhile procedure.

Entities:  

Mesh:

Year:  1991        PMID: 2057752     DOI: 10.1055/s-2007-1004042

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  4 in total

1.  Reliability of ultrasound in the early diagnosis of developmental dysplasia of the hip.

Authors:  K Rosendahl; A Aslaksen; R T Lie; T Markestad
Journal:  Pediatr Radiol       Date:  1995

2.  Developmental dysplasia of the hip: prevalence based on ultrasound diagnosis.

Authors:  K Rosendahl; T Markestad; R T Lie
Journal:  Pediatr Radiol       Date:  1996-09

3.  Ultrasound screening for developmental dysplasia of the hip.

Authors:  Giuseppe Riboni; Aldo Bellini; Sergio Serantoni; Elena Rognoni; Luigi Bisanti
Journal:  Pediatr Radiol       Date:  2003-05-15

Review 4.  Ultrasound in the diagnosis of developmental dysplasia of the hip in newborns. The European approach. A review of methods, accuracy and clinical validity.

Authors:  Karen Rosendahl; Paolo Toma
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 7.034

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.